Study finds public awareness of head and neck cancers low

June 5, 2014

Public awareness of head and neck cancer (HNC) is low, with few Americans knowing much about risk factors such as tobacco use and human papillomavirus (HPV).

HNC is the 10 th most common cancer in the United States. It is a potentially preventable disease with about 75 percent of cases caused by tobacco use. In recent years, HPV has been established as a risk factor for HNC. Increased of HNC and its risk factors could help improve outcomes.

An online study of 2,126 adults was conducted in 2013.

About 66 percent of the participants were "not very" or "not at all" knowledgeable about HNC. Smoking and chewing or spitting tobacco were identified by 54.5 percent and 32.7 percent of respondents as for mouth and throat cancer, respectively. Only 0.8 percent of respondents identified HPV as a risk factor.

"Awareness of HNC is low compared with other cancers, which is concerning given the importance of risk factor avoidance and modification, as well as early patient detection, as drivers of prevention and improved outcomes." Alexander L. Luryi, B.S., of the Yale University School of Medicine, New Haven, Conn. wrote in the paper.

Explore further: HPV-related head & neck cancers rising, highest in middle-aged white men

More information: JAMA Otolaryngol Head Neck Surg. Published online June 5, 2014. DOI: 10.1001/.jamaoto.2014.867

Related Stories

Anal cancer rates quadrupled since mid 70s

June 5, 2014

(Medical Xpress)—Anal cancer rates in the UK have increased by nearly 300 per cent over the last 40 years, according to new figures published by Cancer Research UK.

Recommended for you

Malaria vaccine provides hope for a general cure for cancer

October 13, 2015

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim ...

Breast cancer drug beats superbug

October 13, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.